Effects of acute "binge" cocaine on mRNA levels of μ opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice

Synapse

Volumn 61, Issue 1, 2007, Pages 50-59

  Zhou, Yan ^a   Adomako Mensah, Johannes ^a   Yuferov, Vadim ^a   Ho, Ann ^a   Zhang, Jianhua ^b   Xu, Ming ^c   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Caudate putamen; Frontal cortex; Nucleus accumbens; Stress

Indexed keywords

COCAINE; CORTICOSTERONE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; MU OPIATE RECEPTOR; NEUROPEPTIDE; OREXIN;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CELL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FRONTAL CORTEX; GENE CONTROL; GENE EXPRESSION; LATERAL HYPOTHALAMUS; MALE; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN;

ANIMALS; COCAINE; CORTICOSTERONE; FRONTAL LOBE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, KNOCKOUT; NEUROPEPTIDES; NUCLEUS ACCUMBENS; PRO-OPIOMELANOCORTIN; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D3; RECEPTORS, OPIOID, MU; RECEPTORS, VASOPRESSIN; RNA, MESSENGER;

EID: 33845525206     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20340     Document Type: Article

References (60)

1. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz J, Park B, Gauda E, Lee E, Cool M, Sibiey DR, Gerfen CR, Westphal H, Fuchs S. 1996. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity inmice. Proc Natl Acad Sci USA 93:1945-1949.
2. Azaryan AV, Coughlin LJ, Buzas B, Clock BJ, Cox BM. 1996. Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions. J Neuroehem 66:443-448.
3. Bailey A, Gianotti R, Ho A, Kreek MJ. 2005. Persistent upregulation of mu-opioid, but not adenosine, receptors in brains of longterm withdrawn escalating dose "binge" cocaine-treated rats. Synapse 57:160-166.
4. Borgland S, Taha S, Sarti F, Fields H, Bonci A. 2006. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601.
5. Borowsky B, Kuhn CM. 1991. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenai activation. J Pharmacol Exp Ther 256:204-210.
6. Boutrel B, Kenny PJ, Specio SE,. Martin-Fardon R, Markou A, Koob GF, de Lecea L. 2005. Bole for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA 102:19168-19173.
7. Branch AD, Unterwald EM, Lee SE, Kreek MJ. 1992. Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Mol Brain Res 14:231-238.
8. Bubser M, Fadel JR, Jackson LL, Meador-Woodruff JH, Jing D, Deutch AY. 2005. Dopaminergic regulation of orexin neurons. Eur J Neurosci 21:2993-3001.
9. Caine SB, Gabriel KI, Zhang J, Xu M. 2002. Decreased cocaine self-administration in dopamine D1 receptor knockout mice. Drug Alcohol Depend 66:825.
10. Capriles N, Rodaros D, Sorge RE, Stewart J. 2003. A role of the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology 168:66-74.
11. Carta A, Gerfen CR, Steiner H. 2000. Cocaine effects on gene regulation in the striatum and behavior: Increased sensitivity in D3 receptor-deficient mice. Neuroreport 11:2395-2399.
12. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloruform extraction. Anal Biochem 162:156-159.
13. Chou TC, Lee CE. Lu J, Elmquist JK. Hara J, Willie JT, Beuchmann CT, Chemelli RM, Sakurai T, Yanagisawa M, Saper CB. Scammell TE. 2001. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21:RC168.
14. de Lecea L, Kilduff TS, Peyrori C. Gao XB. Foye PE, Danielson PE, Fukuhara C, Battenberg ELF, Gautvik VT, Bartlett FS II, Frankel WN, Van den Pol AN. Bloom FE, Gautvik KM, Sutcliffe JG. 1998. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322-327.
15. Drago J, Gerfen CR, Westphal H, Steiner H. 1996. D1 dopamine receptor-deficient mouse: Cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 74:813-823.
16. Fadel J, Deutch AY. 2002. Anatomical substrates of orexin-dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111:379-387.
17. Georgescu D, Zachariou V, Barrel M, Mieda M, Willie JT, Eisch AJ. Yanagisawa M, Nestler EJ, Dileone RJ. 2003. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106-3111.
18. Goeders NE, Smith JE. 1983. Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773-775.
19. Goeders NE, Smith JE. 1986. Reinforcing properties of cocaine in medial prefrontal cortex: Primary action on presynaptic dopaminergic terminals. Pharmacol Biochem Behav 25:191-199.
20. Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M, Endres CJ, Dannals RF, Frost JJ. 2005. Imaging brain muopioid receptors in abstinent cocaine users: Time course and relation to cocaine craving. Biol Psychiatry 57:1573-1582.
21. Gurevich EV, Joyce JN, 1999. Distribution of dopamine D3 receptor expressing neurons in human forebrain: Comparison with D2 receptor neurons. Neuropsychopharmacology 20:60-80.
22. Gurkovskaya OV, Palamarchouk V, Smagin G, Goeders NE. 2005. Effects of corticotrophin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats. Synapse 57:202-212.
23. Harris GC, Wimmer M, Aston-Jones G. 2005. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556-559.
24. Homberg JB, van den Akker M, Raaso HS, Warden G, Binnekade R, Schoffelmeer AN, de Vries TJ. 2002. Enhanced motivation to self-administer cocaine is predicted by self-grooming behavior and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur J Neurosci 15:1542-1550.
25. Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, De La Calle A. 1998. Differential regional and cellular distribution of dopamine D2-like receptors: An immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol 402:353-371.
26. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. 2003. Excitation of ventral tegmental area dopaminergic and non-dopaminergic neurons by orexins/hypocretins. J Neurosci 23:7-11.
27. Kreek MJ, LaForge KS, Butelman E. 2002. Pharmacotherapy of addictions. Nat Rev Drug Discov 1:710-726.
28. Leri F, Zhou Y, Goddard B, Cummins E, Kreek MJ. 2006. Effects of high dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and μ -opioid receptor mRNA expression in the rat brain. Neuropsychopharmacology 31:1462-1474.
29. Maggos C, Tsukada H, Kakiuchi T, Nishiyama S, Myers JE, Kreuter J, Schlussman SD, Unterwald EM, Ho A, Kreek MJ. 1998. Sustained withdrawal allows normalization of in vivo [11C]N-methyl-spiperone dopamine D2 receptor binding after chronic "binge" cocaine: A positron emission tomography study in rats. Neuropsychopharmacology 19:146-153.
30. Maggos CE, Spangler R, Zhou Y, Schlussman SD, Ho A, Kreek MJ. 1997. Quantitation of dopamine transporter mRNA in the rat brain: Mapping, effects of "binge" cocaine administration and withdrawal. Synapse 26:55-61.
31. Maisonneuve I, Ho A, Kreek MJ. 1995. Chronic cocaine "binge" administration alters basal extracellular levels in rats: An in vivo microdialysis study. J Pharmacol Exp Ther 272:652-657.
32. McFarland K, Kalivas PW. 2001. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21: 8655-8663.
33. McGregor A, Baker G, Roberts DC. 1996. Effects of 6-hydroxydopamine lesions of the medial frontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 53:5-9.
34. Moore RJ, Vinsant SL, Nader MA, Porrino LJ, Friedman DP. 1998. Effects of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 30:88-96.
35. Narite M, Nagumo Y, Hashimoto S, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Shioda S, Suzuki T. 2006. Direct involvement of orexinergic systems in the activation of mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26:398-405.
36. Rocha B, Fumagalli F, Gainetdinov R, Jones S, Ator R, Giros B, Miller G, Caron M. 1998. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1:132-137.
37. Sanchez CJ, Bailie TM, Wu WR, Sorg BA. 2003. Manipulation of dopamine D1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 119:497-505.
38. Saper CB, Scammell TE, Lu J. 2005. Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257-1263.
39. Schenk S, Horger B, Peltier R, Shelton K. 1991. Supersensitivity to reinforcing effects of cocaine following 6-hydroxydopamine lesions to medial prefrontal cortex in rats. Brain Res 543:227-235.
40. See RE. 2002. Neurol substrates of conditioned-eued relapse to drug-seeking behavior. Pharmacol Biochem Behav 71:517-529.
41. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR. 2001. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98:5300-5305.
42. Sun W, Rebee GV. 2005. The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats. Psychopharmacology 177:315-323.
43. Unterwald EM, Home-King J, Kreek MJ. 1992. Chronic cocaine alters brain μ-opioid receptors. Brain Res 584:314-318.
44. Vittoz NM, Berridge CW. 2006. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: Involvement of the ventral tegmental area. Neuropsychopharmacology 31:384-395.
45. Volkow ND, Fowler JS. 2000. Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cereb Cortex 10: 318-325.
46. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer KL, Dewey SL, Wolf AP. 1993. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177.
47. Winsky-Sommerer R, Boutrel B, de Lecea L. 2005. Stress and arousal: The corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 32:285-294.
48. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. 2001. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21:1787-1794.
49. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S. 1994a. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742.
50. Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S. 1994b. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955.
51. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybiel AM, White FJ, Tonegawa S. 1997. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19:837-848.
52. Yao L, McFarland K, Fan P, Jiang Z, Inoue Y, Diamond I. 2005. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. Proc Natl Acad Sci USA 102:8746-8751.
53. Yuferov VP, Zhou Y, Spangler R, Maggos CE, Ho A, Kreek MJ. 1999. Acute "binge" cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system. Brain Res Bull 48:109-112.
54. Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y, Zhang J, Xu M. 2004. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 24:3344-3354.
55. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ. 1996. Corticotropin-releasing factor and CRF-R1 mRNAs in rat brain and pituitary during "binge" pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 279:351-358.
56. Zhou Y, Schlussman SD, Ho A, Spangler R, Fienberg AA, Greengard P, Kreek MJ. 1999. Effects of chronic "binge" cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32. Neuroendocrinology 70:196-199.
57. Zhou Y, Unterwald EM, Ho A, LaForge KS, Yuferov VP, Kreuter J, Allen RG, Kreek MJ. 2001. Ablation of pituitary proopiomelanocortin (POMC) cells produces alterations in hypothalamic POMC mRNA levels and midbrain mu-opioid receptor binding in a transgenic mouse model. J Neuroendocrinol 13: 808-817.
58. Zhou Y, Spangler R, Yuferov V, Schlussman SD, Ho A, Kreek MJ. 2004. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus. Mol Brain Res 130:61-67.
59. Zhou Y, Bendor J, Hofmann L, Randesi M, Ho A, Kreek MJ. muopioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine with-drawal. J Endocrinol (in press).
60. Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ. 1996. Increased mu-opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 2:1225-1229.